Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne

NCT01293552 is registered in ClinicalTrials.gov with Anterios Inc. as lead sponsor.

NCT NCT01293552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01293552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Lead sponsor
Anterios Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2012
Enrollment
72 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris